All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Molecular modeling studies on the interactions of aflatoxin B1 and its metabolites with human acetylcholinesterase. Part II: Interactions with the catalytic anionic site (CAS)

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18470%2F18%3A50014699" target="_blank" >RIV/62690094:18470/18:50014699 - isvavai.cz</a>

  • Alternative codes found

    RIV/60162694:G44__/18:43889634

  • Result on the web

    <a href="https://www.mdpi.com/2072-6651/10/10/389" target="_blank" >https://www.mdpi.com/2072-6651/10/10/389</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3390/toxins10100389" target="_blank" >10.3390/toxins10100389</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Molecular modeling studies on the interactions of aflatoxin B1 and its metabolites with human acetylcholinesterase. Part II: Interactions with the catalytic anionic site (CAS)

  • Original language description

    The most common type of aflatoxin (AFT) found in nature is aflatoxin B1 (AFB1). This micotoxin is extremely hepatotoxic and carcinogenic to mammals, with acute and chronic effects. It is believed that this could be related to the capacity of AFB1 and its metabolites in inhibiting the enzyme acetylcholinesterase (AChE). In a previous work, we performed an inedited theoretical investigation on the binding modes of these molecules on the peripheral anionic site (PAS) of human AChE (HssAChE), revealing that the metabolites can also bind in the PAS in the same way as AFB1. Here, we investigated the binding modes of these compounds on the catalytic anionic site (CAS) of HssAChE to compare the affinity of the metabolites for both binding sites as well as verify which is the preferential one. Our results corroborated with experimental studies pointing to AFB1 and its metabolites as mixed-type inhibitors, and pointed to the residues relevant for the stabilization of these compounds on the CAS of HssAChE. © 2018 by the authors.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30107 - Medicinal chemistry

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2018

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Toxins

  • ISSN

    2072-6651

  • e-ISSN

  • Volume of the periodical

    10

  • Issue of the periodical within the volume

    10

  • Country of publishing house

    CH - SWITZERLAND

  • Number of pages

    11

  • Pages from-to

    1-11

  • UT code for WoS article

    000448820400010

  • EID of the result in the Scopus database

    2-s2.0-85054136518